KARSEN PERRY A

CIK 000126057313 companiesSUMMIT, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001260573

Recent Transactions

50 trades

Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2023-07-19+20,000→ 20,000 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−15,700→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−20,000→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−15,700→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−16,260→ 0 total
Disposition from Tender
Jounce Therapeutics, Inc.
Common Stock
2023-05-03−5,000→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−15,700→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−75,880→ 0 total
Disposition to Issuer
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2023-05-03−13,350→ 0 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-24+20,000→ 20,000 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2022-06-21+20,000→ 20,000 total
Conversion
LENZ Therapeutics, Inc.$LENZ
Series B Preferred Stock
2021-06-29−19,763→ 0 total
Conversion
LENZ Therapeutics, Inc.$LENZ
Common Stock
2021-06-29+8,126→ 164,034 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-18+15,700→ 15,700 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2021-03-17+18,698→ 18,698 total
Award
LENZ Therapeutics, Inc.$LENZ
Series B Preferred Stock
2021-03-11$5.06/sh+19,763→ 19,763 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2021-01-13+74,794→ 74,794 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-12-17−19,000→ 0 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-17$52.52/sh−21,978→ 71,786 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-17$15.78/sh+19,000→ 93,764 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-17$25.98/sh+19,000→ 74,764 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-12-17−31,764→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-17$18.00/sh+31,764→ 36,764 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-17$54.33/sh−21,336→ 5,000 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-12-17−19,000→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-12-17−19,000→ 0 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-17$53.69/sh−45,450→ 26,336 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2020-12-17$14.35/sh+19,000→ 55,764 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-26+15,700→ 15,700 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-26+13,550→ 13,550 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2020-06-18+19,000→ 19,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2019-06-13+15,000→ 15,000 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2019-06-12+15,700→ 15,700 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2019-05-21+19,000→ 19,000 total
Disposition from Tender
OncoMed Pharmaceuticals Inc
Common Stock
2019-04-23−80,500→ 0 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-06-22+15,000→ 15,000 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2018-06-19+13,550→ 13,550 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2018-06-14+15,000→ 15,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2018-05-17+19,000→ 19,000 total
Award
OncoMed Pharmaceuticals Inc
Common Stock
2018-02-26+70,500→ 80,500 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-02-26+120,000→ 120,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2017-06-29+15,000→ 15,000 total
Purchase
OncoMed Pharmaceuticals Inc
Common Stock
2017-06-05$3.46/sh+10,000→ 10,000 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-06-01+15,000→ 15,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2017-06-01$11.98/sh+5,000→ 5,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2017-05-18+19,000→ 19,000 total
Purchase
Jounce Therapeutics, Inc.
Common Stock
2017-02-01$16.00/sh+5,000→ 5,000 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2016-06-22+15,000→ 15,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2016-06-15+15,000→ 15,000 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2016-05-05+31,764→ 31,764 total

KARSEN PERRY A

Recent Transactions

Companies

Recent Filings

Address